According to Future Market Insights research, during the projected period, the USA knotless surgical sutures market is expected to grow at a CAGR of 3.6%. The market value is projected to increase from US$ 181.0 Million in 2023 to US$ 258.7 Million by 2033. The USA knotless surgical sutures was valued at US$ 175.7 Million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 3.1% in 2023.
Market Outlook:
| Data Points | Market Insights |
|---|---|
| Market Value 2022 | US$ 175.7 Million |
| Market Value 2023 | US$ 181.0 Million |
| Market Value 2033 | US$ 258.7 Million |
| CAGR 2023 to 2033 | 3.6% |
| Share of Top 5 Companies | 32.1% |
| Key Players | The key players in the knotless surgical sutures market are Medtronic; B. Braun Melsungen AG; Teleflex Incorporated; Johnson & Johnson (Ethicon); CONMED Corporation; Corza Medical; CP Medical; DemeTECH Corporation; Sutumed; DSI Dental Solution; Golnit Sutures; Vital Sutures; Atramat; Unilene; Advanced MedTech Solutions Pvt. Ltd; Dolphin Sutures; Arthrex; Inc; GMD Group; Dynek Pvt Ltd; Kono Seisakusho Co.;Ltd ); Olimp- Surgical Sutures; Lotus Surgicals; Unisur Lifecare Pvt Ltd. |
The knotless barbed suture is a monofilament suture specifically designed with barbs. It is a new kind of suture designed for use in both skin and deeper structures. The suture is orientated in the opposite direction to the needle. Post-injury, knotless sutures hold tissues together and enhance the natural process of healing. They are commonly used on the skin, internal tissues, organs and blood vessels.
Overall, the technological advancements in sutures is likely to boost the market in the coming years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of the knotless surgical sutures market in the USA grew at a CAGR of 2.3% from 2015 to 2022. The USA knotless surgical sutures market contributes around 37.7% revenue share to the global knotless surgical sutures market in 2022, which was valued at US$ 465.6 Million.
The surgical suture industry has seen some significant advances in technology in recent years. The use of synthetic materials with outstanding tissue-holding capabilities and lower risk of infection and scarring, suture coatings, braiding technologies, barbed sutures, and novel specialised sutures that are in development are some of the breakthroughs in surgical sutures.
Triclosan-coated polyglactin 910 (Vicryl Plus Antibacterial: Ethicon) has been reported to reduce the prevalence of surgical site infections by 30%. These sutures were discovered to have similar handling and tension forces to those of common suture materials. Despite being relatively non-toxic, triclosan has been known to cause skin rashes and allergic reactions.
The increasing aging population and rising incidence of traffic accidents, trauma, burns, cosmetic, orthopedic, cardiovascular, and other surgical procedures offer significant market potential for surgical sutures.
Accidents can result in significant tissue damage, requiring reconstructive surgeries to restore the affected area's form and function. Knotless surgical sutures play a role in reconstructive procedures by providing precise and secure wound closure, which is essential for successful outcomes. The rise in accident cases can lead to an increased demand for reconstructive surgeries, indirectly driving the demand for knotless surgical sutures.
Principal Consultant
The market for surgical sutures is anticipated to see certain growth restraints due to the rising adoption of substitute wound closure techniques including skin adhesives and tissue sealants. Manufacturers in the USA market for knotless surgical sutures compete with domestic and international businesses across all of their product lines.
When compared to suturing, a lengthy wound can be stapled in 25–50% less time. If used properly, staples can help reduce tissue stress. Staples are very strong and are excellent for closing wounds that are under significant tension. Staples are also generally painless to remove and offer great wound reversal.
The development of surgical adhesives and sealants has provided an alternative method of wound closure in certain surgical procedures. These products can be used in place of traditional sutures, including knotless surgical sutures, to achieve wound closure. The use of surgical adhesives and sealants may reduce the demand for knotless sutures in specific surgical applications.
The Northeast USA dominated the USA market with a value share of around 29.0% in 2022.
Northeast USA has a high healthcare expenditure, and patients are more willing to spend money on effective treatments for knotless surgical sutures. This trend is driving the growth of the market as more patients seek treatment options that can provide them with required care. The growing prevalence of number of accidents such as road accidents and trauma are driving the demand for surgical sutures in the Northeast state of USA and thereby, increase in the adoption of knotless surgical sutures.
Midwest is projected to be the most attractive market in knotless sutures growing at a CAGR of close to 4.1% over the forecast period.
In the United States, knotless surgical sutures are gaining popularity, especially in the Midwest, where there is an increasing need for quick and affordable surgical sutures. The market is anticipated to rise as Knotless Sutures become more widely used. The Midwest market is predicted to grow quickly as the use of technologies such human tendons and tough gel sutures, which have the potential to considerably boost operating efficiency, grows.
Such futuristic steps and missions are going to escalate Midwest’s knotless surgical sutures market in the projected period.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The absorbable surgical sutures segment held the major chunk of 61.0% of the USA market by the end of 2022.
Absorbable sutures can break down naturally over the time, within the body itself. They eliminate the need for suture removal, which can be beneficial for patients and reduce the risk of complications associated with suture removal procedures.
Absorbable sutures are commonly used for internal tissues that heal relatively quickly or in areas that are difficult to access for suture removal.
Polyglactin absorbable surgical sutures were the predominant segment with a market share of 22.4% in the USA market by the end of 2022.
Polyglactin sutures offer adequate tensile strength, allowing them to hold tissues together during the critical healing period. The sutures maintain their strength for a sufficient duration, providing support until the wound heals. Polyglactin sutures are biodegradable, meaning they break down into biocompatible byproducts that can be metabolized and eliminated by the body. This property eliminates the need for suture removal procedures.
As it is the mostly used raw material, it holds significant market share in the USA market.
The synthetic source segment is accounted for a revenue share of 51.3% in the USA market at the end of 2022.
Synthetic knotless sutures often utilize innovative anchoring mechanisms or self-locking technology to secure the suture in place without the need for knots. These mechanisms can provide reliable and secure closure, minimizing the risk of suture slippage or failure.
The cardiovascular procedures segment accounted for a revenue share of 32.2% in the USA market at the end of 2022.
In cardiac surgery, it is possible to close the right atrium cannulation site with knotless barbed sutures and an extra self-locking technique without any immediate or long-term consequences. This creates opportunities for minimally invasive heart surgery employing knotless barbed sutures. This work demonstrates that barbed knotless sutures effectively close a low-pressure heart structure, which could speed up minimally invasive surgery.
The hospital laboratories accounted for a revenue share of 34.9% in the USA market at the end of 2022.
Hospital laboratories plays a role in evaluating the performance and characteristics of various sutures, including knotless sutures, through testing and research. They might assess factors such as suture strength, biocompatibility, and tissue response. These evaluations can contribute to the understanding and selection of appropriate sutures for surgical procedures.
Among the primary approaches used by organizations to get a competitive edge in the market are new launches, technical advancements, and regulatory compliance, acquisition and distribution agreements with other businesses to expand their business.
For instance:
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in USA knotless surgical sutures market space, which are available in the full report.
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2015 to 2022 |
| Market Analysis | USD Million for Value |
| Key Country Covered | USA |
| Key States Covered | Northeast, Midwest, Southeast, Southwest, West |
| Key Segments Covered | Product, Raw Material, Source, Application End User, and Region |
| Key Companies Profiled | Medtronic; B. Braun Melsungen AG; Teleflex Incorporated; Johnson & Johnson (Ethicon); CONMED Corporation; Corza Medical; CP Medical; DemeTECH Corporation; Sutumed; DSI Dental Solution; Golnit Sutures; Vital Sutures; Atramat; Unilene; Advanced MedTech Solutions Pvt. Ltd; Dolphin Sutures; Arthrex, Inc; GMD Group; Dynek Pvt Ltd; Kono Seisakusho Co.,Ltd); Olimp- Surgical Sutures; Lotus Surgicals; Unisur Lifecare Pvt Ltd. |
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 181 million in 2023.
The Market is estimated to develop at a CAGR of 3.6%.
The market is estimated to reach US$ 258.7 million by 2033.
The top 5 companies are expected to hold 32.1% of the market.
Healthcare spending, accident rates, and innovation are the key opportunities.
1. Executive Summary
1.1. USA Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value-Added Insights
4.1. Product Adoption / Usage Analysis
4.2. Branding and Promotional Strategies
4.3. Reimbursement Landscape
4.4. Regulatory Scenario
4.5. PESTLE Analysis
4.6. Porter’s Analysis
5. Market Demand Analysis 2015 to 2022 and Forecast, 2023 to 2033
5.1. Historical Market Volume (Units) Analysis, 2015 to 2022
5.2. Current and Future Market Volume (Units) Projections, 2023 to 2033
5.2.1. Y-o-Y Growth Trend Analysis
6. Market - Pricing Analysis
6.1. Regional Pricing Analysis By Product
6.2. Pricing Break-up
6.2.1. Manufacturer-Level Pricing
6.2.2. Distributor Level Pricing
6.3. USA Average Pricing Analysis Benchmark
6.4. Pricing Assumptions
7. Market Demand (in Value or Size in US$ Million) Analysis 2015 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Market Background
8.1. Macro-Economic Factors
8.1.1. Gross Domestic Product by Region & Country,
8.1.2. USA Per-Capita Healthcare Expenditure
8.2. Forecast Factors - Relevance & Impact
8.2.1. Historical Growth of Top Brands
8.2.2. Rise in the number of surgeries
8.2.3. Rising Demand in Emerging Economies
8.2.4. Strategic Mergers and Acquisitions
8.2.5. Local Player Growth
8.2.6. Rise in Number of Amputation Surgeries
8.2.7. Increase in Trauma cases
8.3. Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Opportunity Analysis
8.4. Covid-19 Analysis
9. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Product
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2015 to 2022
9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033
9.3.1. Absorbable Surgical Sutures
9.3.2. Non-Absorbable Surgical Sutures
9.4. Market Attractiveness Analysis By Product
10. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Raw Material
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Raw Material, 2015 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Raw Material, 2023 to 2033
10.3.1. Polyglycolic Acid Absorbable Surgical Sutures
10.3.2. Polyglactin Absorbable Surgical Sutures
10.3.3. Catgut Absorbable Surgical Sutures
10.3.4. Linen Absorbable Surgical Sutures
10.3.5. Cotton Absorbable Surgical Sutures
10.3.6. Nylon (poylamide) Non-Absorbable Surgical Sutures
10.3.7. Polyester Non-Absorbable Surgical Sutures
10.3.8. Polyvinylidene fluoride(PVDF) Non-Absorbable Surgical Sutures
10.3.9. Silk Non-Absorbable Surgical Sutures
10.3.10. Stainless Steel Non-Absorbable Surgical Sutures
10.4. Market Attractiveness Analysis By Raw Material
11. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Source
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Source, 2015 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Source, 2023 to 2033
11.3.1. Natural
11.3.2. Synthetic
11.3.2.1. Multifilament
11.3.2.2. Braided
11.3.3. Coated
11.3.4. Uncoated
11.4. Market Attractiveness Analysis By Source
12. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Application
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
12.3.1. Cardiovascular Procedures
12.3.2. General Surgery Procedures
12.3.3. Ophthalmic Procedures
12.3.4. Orthopedic Procedures
12.3.5. Dental Procedures
12.3.6. Gastroenterology Procedures
12.3.7. Gynecology Procedures
12.3.8. Plastic Surgery Procedures
12.3.9. Veterinary Procedures
12.4. Market Attractiveness Analysis, By Application
13. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by End User
13.1. Introduction / Key Findings
13.2. Historical Market Size (US$ Million) Analysis By End User, 2015 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
13.3.1. Hospitals
13.3.2. Clinics
13.3.3. Ambulatory Surgical Centers
13.3.4. Group Dental Practice
13.3.5. Veterinary Hospitals
13.3.6. Veterinary Clinics
13.4. Market Attractiveness Analysis By End User
14. Market Analysis 2015 to 2022 and Forecast 2023 to 2033, by Region
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Region, 2023 to 2033
14.3.1. Northeast USA
14.3.2. Midwest USA
14.3.3. Southeast USA
14.3.4. Southwest USA
14.3.5. East USA
14.4. Market Attractiveness Analysis By Region
15. Northeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
15.3.1. By Product
15.3.2. By Raw Material
15.3.3. By Source
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Raw Material
15.4.3. By Source
15.4.4. By Application
15.4.5. By End User
16. Midwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16.3.1. By Product
16.3.2. By Raw Material
16.3.3. By Source
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Product
16.4.2. By Raw Material
16.4.3. By Source
16.4.4. By Application
16.4.5. By End User
17. Southeast USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
17.3.1. By Product
17.3.2. By Raw Material
17.3.3. By Source
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Product
17.4.2. By Raw Material
17.4.3. By Source
17.4.4. By Application
17.4.5. By End User
18. Southwest USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
18.3.1. By Product
18.3.2. By Raw Material
18.3.3. By Source
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Product
18.4.2. By Raw Material
18.4.3. By Source
18.4.4. By Application
18.4.5. By End User
19. West USA Market Analysis 2015 to 2022 and Forecast 2023 to 2033
19.1. Introduction
19.2. Historical Market Size (US$ Million) and Volume (Units) Trend Analysis By Market Taxonomy, 2015 to 2022
19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
19.3.1. By Product
19.3.2. By Raw Material
19.3.3. By Source
19.3.4. By Application
19.3.5. By End User
19.4. Market Attractiveness Analysis
19.4.1. By Product
19.4.2. By Raw Material
19.4.3. By Source
19.4.4. By Application
19.4.5. By End User
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies (Surgical Sutures)
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.3.1. Regional Footprint of Players
20.3.2. Product Footprint by Players
20.3.3. Channel Footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Key Development Analysis
21.3. Competition Benchmarking
21.4. Competition Deep Dive
21.4.1. Medtronic Plc
21.4.1.1. Overview
21.4.1.2. Product Portfolio
21.4.1.3. key Financials
21.4.1.4. Sales Footprint
21.4.1.5. Strategy Overview
21.4.1.5.1. Marketing Strategy
21.4.1.5.2. Product Strategy
21.4.1.5.3. Channel Strategy
21.4.2. B. Braun Melsungen AG
21.4.2.1. Overview
21.4.2.2. Product Portfolio
21.4.2.3. key Financials
21.4.2.4. Sales Footprint
21.4.2.5. Strategy Overview
21.4.2.5.1. Marketing Strategy
21.4.2.5.2. Product Strategy
21.4.2.5.3. Channel Strategy
21.4.3. Teleflex Incorporated
21.4.3.1. Overview
21.4.3.2. Product Portfolio
21.4.3.3. key Financials
21.4.3.4. Sales Footprint
21.4.3.5. Strategy Overview
21.4.3.5.1. Marketing Strategy
21.4.3.5.2. Product Strategy
21.4.3.5.3. Channel Strategy
21.4.4. Johnson & Johnson (Ethicon)
21.4.4.1. Overview
21.4.4.2. Product Portfolio
21.4.4.3. key Financials
21.4.4.4. Sales Footprint
21.4.4.5. Strategy Overview
21.4.4.5.1. Marketing Strategy
21.4.4.5.2. Product Strategy
21.4.4.5.3. Channel Strategy
21.4.5. CONMED Corporation
21.4.5.1. Overview
21.4.5.2. Product Portfolio
21.4.5.3. key Financials
21.4.5.4. Sales Footprint
21.4.5.5. Strategy Overview
21.4.5.5.1. Marketing Strategy
21.4.5.5.2. Product Strategy
21.4.5.5.3. Channel Strategy
21.4.6. Corza Medical
21.4.6.1. Overview
21.4.6.2. Product Portfolio
21.4.6.3. key Financials
21.4.6.4. Sales Footprint
21.4.6.5. Strategy Overview
21.4.6.5.1. Marketing Strategy
21.4.6.5.2. Product Strategy
21.4.6.5.3. Channel Strategy
21.4.7. CP Medical
21.4.7.1. Overview
21.4.7.2. Product Portfolio
21.4.7.3. key Financials
21.4.7.4. Sales Footprint
21.4.7.5. Strategy Overview
21.4.7.5.1. Marketing Strategy
21.4.7.5.2. Product Strategy
21.4.7.5.3. Channel Strategy
21.4.8. DemeTECH Corporation
21.4.8.1. Overview
21.4.8.2. Product Portfolio
21.4.8.3. key Financials
21.4.8.4. Sales Footprint
21.4.8.5. Strategy Overview
21.4.8.5.1. Marketing Strategy
21.4.8.5.2. Product Strategy
21.4.8.5.3. Channel Strategy
21.4.9. Sutumed
21.4.9.1. Overview
21.4.9.2. Product Portfolio
21.4.9.3. key Financials
21.4.9.4. Sales Footprint
21.4.9.5. Strategy Overview
21.4.9.5.1. Marketing Strategy
21.4.9.5.2. Product Strategy
21.4.9.5.3. Channel Strategy
21.5. 21.4.7. DSI Dental Solution
21.5.1.1. Overview
21.5.1.2. Product Portfolio
21.5.1.3. key Financials
21.5.1.4. Sales Footprint
21.5.1.5. Strategy Overview
21.5.1.5.1. Marketing Strategy
21.5.1.5.2. Product Strategy
21.5.1.5.3. Channel Strategy
21.6. 21.4.8. Golnit Sutures
21.6.1.1. Overview
21.6.1.2. Product Portfolio
21.6.1.3. key Financials
21.6.1.4. Sales Footprint
21.6.1.5. Strategy Overview
21.6.1.5.1. Marketing Strategy
21.6.1.5.2. Product Strategy
21.6.1.5.3. Channel Strategy
21.6.2. Vital Sutures
21.6.2.1. Overview
21.6.2.2. Product Portfolio
21.6.2.3. key Financials
21.6.2.4. Sales Footprint
21.6.2.5. Strategy Overview
21.6.2.5.1. Marketing Strategy
21.6.2.5.2. Product Strategy
21.6.2.5.3. Channel Strategy
21.6.3. Atramat
21.6.3.1. Overview
21.6.3.2. Product Portfolio
21.6.3.3. key Financials
21.6.3.4. Sales Footprint
21.6.3.5. Strategy Overview
21.6.3.5.1. Marketing Strategy
21.6.3.5.2. Product Strategy
21.6.3.5.3. Channel Strategy
21.6.4. Unilene
21.6.4.1. Overview
21.6.4.2. Product Portfolio
21.6.4.3. key Financials
21.6.4.4. Sales Footprint
21.6.4.5. Strategy Overview
21.6.4.5.1. Marketing Strategy
21.6.4.5.2. Product Strategy
21.6.4.5.3. Channel Strategy
21.6.5. Hiossen
21.6.5.1. Overview
21.6.5.2. Product Portfolio
21.6.5.3. key Financials
21.6.5.4. Sales Footprint
21.6.5.5. Strategy Overview
21.6.5.5.1. Marketing Strategy
21.6.5.5.2. Product Strategy
21.6.5.5.3. Channel Strategy
21.7. 21.4.12 Advanced MedTech Solutions Pvt. Ltd
21.7.1.1. Overview
21.7.1.2. Product Portfolio
21.7.1.3. key Financials
21.7.1.4. Sales Footprint
21.7.1.5. Strategy Overview
21.7.1.5.1. Marketing Strategy
21.7.1.5.2. Product Strategy
21.7.1.5.3. Channel Strategy
21.7.2. Dolphin Sutures
21.7.2.1. Overview
21.7.2.2. Product Portfolio
21.7.2.3. key Financials
21.7.2.4. Sales Footprint
21.7.2.5. Strategy Overview
21.7.2.5.1. Marketing Strategy
21.7.2.5.2. Product Strategy
21.7.2.5.3. Channel Strategy
21.7.3. Arthrex, Inc
21.7.3.1. Overview
21.7.3.2. Product Portfolio
21.7.3.3. key Financials
21.7.3.4. Sales Footprint
21.7.3.5. Strategy Overview
21.7.3.5.1. Marketing Strategy
21.7.3.5.2. Product Strategy
21.7.3.5.3. Channel Strategy
21.8. 21.4.15 GMD Group
21.8.1.1. Overview
21.8.1.2. Product Portfolio
21.8.1.3. key Financials
21.8.1.4. Sales Footprint
21.8.1.5. Strategy Overview
21.8.1.5.1. Marketing Strategy
21.8.1.5.2. Product Strategy
21.8.1.5.3. Channel Strategy
21.9. 21.4.16 Dynek Pvt Ltd
21.9.1.1. Overview
21.9.1.2. Product Portfolio
21.9.1.3. key Financials
21.9.1.4. Sales Footprint
21.9.1.5. Strategy Overview
21.9.1.5.1. Marketing Strategy
21.9.1.5.2. Product Strategy
21.9.1.5.3. Channel Strategy
21.10. 21.4.17 Kono Seisakusho Co.,Ltd
21.10.1.1. Overview
21.10.1.2. Product Portfolio
21.10.1.3. key Financials
21.10.1.4. Sales Footprint
21.10.1.5. Strategy Overview
21.10.1.5.1. Marketing Strategy
21.10.1.5.2. Product Strategy
21.10.1.5.3. Channel Strategy
21.11. 21.4.17 Olimp- Surgical Sutures
21.11.1.1. Overview
21.11.1.2. Product Portfolio
21.11.1.3. key Financials
21.11.1.4. Sales Footprint
21.11.1.5. Strategy Overview
21.11.1.5.1. Marketing Strategy
21.11.1.5.2. Product Strategy
21.11.1.5.3. Channel Strategy
21.12. 21.4.18 Lotus Surgicals
21.12.1.1. Overview
21.12.1.2. Product Portfolio
21.12.1.3. key Financials
21.12.1.4. Sales Footprint
21.12.1.5. Strategy Overview
21.12.1.5.1. Marketing Strategy
21.12.1.5.2. Product Strategy
21.12.1.5.3. Channel Strategy
21.13. 21.4.19 Unisur Lifecare Pvt Ltd.
21.13.1.1. Overview
21.13.1.2. Product Portfolio
21.13.1.3. key Financials
21.13.1.4. Sales Footprint
21.13.1.5. Strategy Overview
21.13.1.5.1. Marketing Strategy
21.13.1.5.2. Product Strategy
21.13.1.5.3. Channel Strategy
22. Assumptions and Acronyms Used
23. Research Methodology
Explore Healthcare Insights
View Reports
USA Knotless Surgical Sutures Market
